Xing‐Hua Liao

2.2k total citations
74 papers, 1.7k citations indexed

About

Xing‐Hua Liao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xing‐Hua Liao has authored 74 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 35 papers in Cancer Research and 16 papers in Oncology. Recurrent topics in Xing‐Hua Liao's work include Cancer-related molecular mechanisms research (20 papers), MicroRNA in disease regulation (19 papers) and RNA modifications and cancer (15 papers). Xing‐Hua Liao is often cited by papers focused on Cancer-related molecular mechanisms research (20 papers), MicroRNA in disease regulation (19 papers) and RNA modifications and cancer (15 papers). Xing‐Hua Liao collaborates with scholars based in China, United States and United Kingdom. Xing‐Hua Liao's co-authors include Xiang Yuan, Jia‐Peng Li, Tongcun Zhang, Nan Wang, Zhou‐Tong Dai, Tong‐Cun Zhang, John Evankovich, Jun Xu, Gary Nace and Mark A. Ross and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xing‐Hua Liao

71 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xing‐Hua Liao China 22 1.1k 659 315 233 143 74 1.7k
Feng Jiang China 25 1.2k 1.1× 597 0.9× 244 0.8× 198 0.8× 94 0.7× 70 1.7k
Jianye Xu China 20 1.3k 1.2× 686 1.0× 443 1.4× 184 0.8× 181 1.3× 35 2.1k
Chao Gu China 26 1.2k 1.1× 631 1.0× 348 1.1× 234 1.0× 107 0.7× 82 1.9k
Xia Yang China 28 1.4k 1.3× 795 1.2× 185 0.6× 272 1.2× 149 1.0× 75 2.1k
Zhiwei He China 24 1.1k 1.0× 729 1.1× 161 0.5× 352 1.5× 125 0.9× 89 1.8k
Yuan‐Li Huang Taiwan 30 1.1k 1.1× 548 0.8× 288 0.9× 423 1.8× 204 1.4× 87 2.1k
Zifan Lu China 24 982 0.9× 416 0.6× 208 0.7× 137 0.6× 173 1.2× 72 1.6k
Ying Lu China 26 992 0.9× 564 0.9× 254 0.8× 251 1.1× 213 1.5× 81 1.9k

Countries citing papers authored by Xing‐Hua Liao

Since Specialization
Citations

This map shows the geographic impact of Xing‐Hua Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing‐Hua Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing‐Hua Liao more than expected).

Fields of papers citing papers by Xing‐Hua Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing‐Hua Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing‐Hua Liao. The network helps show where Xing‐Hua Liao may publish in the future.

Co-authorship network of co-authors of Xing‐Hua Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Xing‐Hua Liao. A scholar is included among the top collaborators of Xing‐Hua Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing‐Hua Liao. Xing‐Hua Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Hanning, et al.. (2025). GGCT Inhibits Ferroptosis in PTC Cells by Upregulating p53 Through RPS15A. Cancer Science. 116(6). 1592–1603. 2 indexed citations
2.
Wang, Yibin, Jun Wang, Xing‐Hua Liao, et al.. (2025). Glutathione-activated mitochondria-targeting nanosystem overcoming ferroptosis defence for dual synergism with apoptosis to enhance anti-tumor efficacy of sonodynamic therapy. Chinese Chemical Letters. 111771–111771. 1 indexed citations
3.
Zhao, Lili, Xiang Yuan, Chao Shen, et al.. (2024). The effect of LNCRNA SHANK3 on the malignant development of gastric cancer cells by regulating the miR-4530/MNX1. Translational Oncology. 46. 102000–102000. 1 indexed citations
4.
Wu, Hang, Xing‐Hua Liao, Bin Xie, et al.. (2024). Mechanism of MiR-145a-3p/Runx2 pathway in dexamethasone impairment of MC3T3-E1 osteogenic capacity in mice. PLoS ONE. 19(11). e0309951–e0309951.
5.
Deng, Yang, Jia‐Peng Li, Yingjie Zhang, et al.. (2023). NUF2 Promotes Breast Cancer Development as a New Tumor Stem Cell Indicator. International Journal of Molecular Sciences. 24(4). 4226–4226. 11 indexed citations
6.
Zhang, Wanjun, Xue Zhang, Jun Wang, et al.. (2023). A novel transcription factor SIPA1: identification and verification in triple-negative breast cancer. Oncogene. 42(35). 2641–2654. 3 indexed citations
7.
Ren, Lili, et al.. (2023). GRB10 is a novel factor associated with gastric cancer proliferation and prognosis. Aging. 15(9). 3394–3409. 7 indexed citations
8.
Han, Yue, et al.. (2023). NRP1 regulates autophagy and proliferation of gastric cancer through Wnt/β-catenin signaling pathway. Aging. 15(17). 8613–8629. 8 indexed citations
9.
Yu, Wenjie, Xiyu Liu, Chunping Liu, et al.. (2023). Mitochondria‐Targeted Nanosystem with Reactive Oxygen Species‐Controlled Release of CO to Enhance Photodynamic Therapy of PCN‐224 by Sensitizing Ferroptosis. Small. 19(16). e2206124–e2206124. 62 indexed citations
10.
Feng, Lingyun, Hui Liu, Yuhuan Liu, et al.. (2022). SIPA1 Regulates LINC01615 to Promote Metastasis in Triple-Negative Breast Cancer. Cancers. 14(19). 4815–4815. 7 indexed citations
11.
Wang, Jun, et al.. (2022). Acid/reduction dual-sensitive amphiphilic graft polyurethane with folic acid and detachable poly(ethylene glycol) as anticancer drug delivery carrier. Colloids and Surfaces B Biointerfaces. 222. 113084–113084. 9 indexed citations
12.
Wang, Jun, Huimin Zhang, Zhou‐Tong Dai, et al.. (2022). MKL-1-induced PINK1-AS overexpression contributes to the malignant progression of hepatocellular carcinoma via ALDOA-mediated glycolysis. Scientific Reports. 12(1). 21283–21283. 8 indexed citations
13.
Wu, Han, Chen Chen, Jia‐Peng Li, et al.. (2022). B cell deficiency promotes the initiation and progression of lung cancer. Frontiers in Oncology. 12. 1006477–1006477. 8 indexed citations
14.
Li, Hui, Huimin Zhang, Lijuan Fan, et al.. (2021). STAT3/miR-15a-5p/CX3CL1 Loop Regulates Proliferation and Migration of Vascular Endothelial Cells in Atherosclerosis. International Journal of Medical Sciences. 18(4). 964–974. 16 indexed citations
15.
Huang, Feng, Xiang Yuan, Ting Li, et al.. (2021). Metformin and MiR-365 synergistically promote the apoptosis of gastric cancer cells via MiR-365-PTEN-AMPK axis. Pathology - Research and Practice. 230. 153740–153740. 9 indexed citations
16.
Zhang, Huimin, Hui Li, Jun Wang, et al.. (2020). MKL1/miR-5100/CAAP1 loop regulates autophagy and apoptosis in gastric cancer cells. Neoplasia. 22(5). 220–230. 45 indexed citations
17.
Wang, Nan, et al.. (2015). Protein kinase Cα inhibits myocardin-induced cardiomyocyte hypertrophy through the promotion of myocardin phosphorylation. Acta Biochimica et Biophysica Sinica. 47(9). 687–695. 3 indexed citations
18.
Huang, Hai, John Evankovich, Wei Yan, et al.. (2011). Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice. Hepatology. 54(3). 999–1008. 288 indexed citations
19.
Cao, Xiaohong, et al.. (2010). Gene cloning of phenolic acid decarboxylase from Bacillus subtilis and expression in top-fermenting yeast strain. AFRICAN JOURNAL OF BIOTECHNOLOGY. 9(33). 5284–5291. 3 indexed citations
20.
Wang, Nan, Zhen Zhou, Xing‐Hua Liao, & Tongcun Zhang. (2009). Role of microRNAs in cardiac hypertrophy and heart failure. IUBMB Life. 61(6). 566–571. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026